What is Golomb & Honik?
Golomb & Honik, P.C. operates as a specialized legal entity with a distinct focus on beryllium litigation and pharmaceutical liability, most notably concerning VIOXX-related health complications. The firm occupies a critical niche in the personal injury sector, providing essential legal advocacy for individuals suffering from severe health consequences due to toxic exposure or defective medical products. Their market position is defined by a commitment to rigorous case evaluation and specialized litigation strategies, ensuring that plaintiffs receive professional representation in highly technical legal environments.
How much funding has Golomb & Honik raised?
Golomb & Honik has raised a total of $372K across 2 funding rounds:
Debt
$150K
Debt
$222K
Debt (2020): $150K with participation from PPP
Debt (2021): $222K led by PPP
Key Investors in Golomb & Honik
PPP
Public-Private Partnership
What's next for Golomb & Honik?
With the recent influx of capital, Golomb & Honik is well-positioned to scale its litigation infrastructure and enhance its case management capabilities. The firm is expected to utilize these resources to bolster its research and development in mass tort proceedings, potentially expanding its reach into emerging areas of environmental and pharmaceutical law. As the firm navigates the complexities of late-stage growth, the focus will likely remain on optimizing legal outcomes for clients while maintaining the operational efficiency required to handle large-scale, multi-district litigation efforts effectively.
See full Golomb & Honik company page
